doi: 10.1038/ijo.2016.52 3 DaviesMJBergenstalRBodeBKushnerRFLewinASkjthTVet al
Paper logs should not be dismissed, particularly for older adults or those with limited technology access
Epigenetics identifier screens reveal regulators of chromatin acylation and limited specificity of acylation antibodies
Tirzepatyd jest agonist nie tylko receptora GLP-1, ale rwnie receptora GIP (glukozozalenego peptydu insulinotropowego), co potguje jego wpyw na metabolizm
"Obesity is a chronic disease so we should treat it the same way as, say, high blood pressure, where you just take those drugs every single day for the rest of your life." Suzanne Rose, PhD, Executive Director of Research, Stamford Health If youre considering stopping the medication, its essential to work with your healthcare provider on a structured plan
The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes
